These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 3035513)

  • 1. Proliferation of thyrotropin releasing hormone receptors in specific brain regions during the development of hypertension in spontaneously hypertensive rats.
    Bhargava HN; Das S; Bansinath M
    Peptides; 1987; 8(2):231-5. PubMed ID: 3035513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to spinal cord membranes of spontaneously hypertensive and Wistar-Kyoto normotensive rats.
    Bhargava HN; Gulati A
    Pharmacology; 1988; 37(6):349-55. PubMed ID: 2854272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of 3H-D-Pen2-D-Pen5-enkephalin to brain regions and spinal cord membranes of spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Bhargava HN; Rahmani NH
    Pharmacology; 1993; 46(2):75-81. PubMed ID: 8382821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of the binding of 3H-(3-MeHis2) thyrotropin releasing hormone to rat amygdala membranes by some naturally occurring cannabinoids.
    Bhargava HN; Gulati A
    Peptides; 1988; 9(4):771-5. PubMed ID: 2852360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats.
    Bhargava HN; Das S; Bansinath M; Prasad R
    Pharmacol Biochem Behav; 1989 Sep; 34(1):7-12. PubMed ID: 2516632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel substance P binding site in rat brain regions modulates TRH receptor binding.
    Sharif NA
    Neurochem Res; 1990 Oct; 15(10):1045-9. PubMed ID: 1706485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of central receptors for thyrotropin-releasing hormone in kappa opiate agonist-induced abstinence in the rat.
    Bhargava HN; Gulati A; Rahmani NH
    Neuropharmacology; 1992 Feb; 31(2):137-41. PubMed ID: 1313157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of central binding sites for [3H] DAMGO in spontaneously hypertensive rats.
    Gulati A; Bhargava HN
    Life Sci; 1990; 47(2):159-66. PubMed ID: 2167417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
    Das S; Bhargava HN
    Neuropharmacology; 1987 Aug; 26(8):1141-6. PubMed ID: 2889163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of hyperthyroid rats.
    Bhargava HN; Ramarao P; Gulati A; Matwyshyn GA; Prasad R
    Arch Int Pharmacodyn Ther; 1989; 297():247-59. PubMed ID: 2499290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH; Gulati A; Bhargava HN
    Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opiate antagonist binding sites in discrete brain regions of spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Rahmani NH; Gulati A; Bhargava HN
    Life Sci; 1991; 48(26):2499-504. PubMed ID: 2046475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilization of receptors for thyrotropin-releasing hormone from GH4C1 rat pituitary cells: demonstration of guanyl nucleotide sensitivity.
    Sullivan NJ; Lautens LL; Tashjian AH
    Mol Endocrinol; 1987 Dec; 1(12):889-98. PubMed ID: 2856405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine-induced changes in 3H-naloxone binding in brain membranes isolated from spontaneously hypertensive and Wistar-Kyoto rats.
    Ishizuka Y; Rockhold RW; Hoskins B; Ho IK
    Life Sci; 1988; 43(26):2275-82. PubMed ID: 2850430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanine nucleotide regulation of receptor binding of thyrotropin-releasing hormone (TRH) in rat brain regions, retina and pituitary.
    Sharif NA; Burt DR
    Neurosci Lett; 1987 Oct; 81(3):339-44. PubMed ID: 2829061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain corticotropin releasing factor in the spontaneously hypertensive rat.
    Hattori T; Hashimoto K; Ota Z
    Hypertension; 1986 Nov; 8(11):1027-31. PubMed ID: 3490439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid peptides in pituitary gland, brain regions and peripheral tissues of spontaneously hypertensive and Wistar-Kyoto normotensive rats.
    Bhargava HN; Matwyshyn GA; Hanissian S; Tejwani GA
    Brain Res; 1988 Feb; 440(2):333-40. PubMed ID: 2896047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central serotonergic uptake mechanisms in hypertensive rats: effects of clonidine and centhaquin.
    Gulati A; Arora RC; Crayton J
    Eur J Pharmacol; 1993 Feb; 231(2):151-6. PubMed ID: 8453971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. Part II.
    Gattu M; Terry AV; Pauly JR; Buccafusco JJ
    Brain Res; 1997 Oct; 771(1):104-14. PubMed ID: 9383013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin-releasing hormone hyperactivity in the preoptic area of spontaneously hypertensive rats.
    Garcia SI; Dabsys SM; Martinez VN; Delorenzi A; Santajuliana D; Nahmod VE; Finkielman S; Pirola CJ
    Hypertension; 1995 Dec; 26(6 Pt 2):1105-10. PubMed ID: 7498977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.